Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_13375 | 48 | 1.00 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.091 | 1.421 | 0.99962 | 1.00000 | |
RegionR2 | 6.043 | 1.421 | 0.00008 | 0.00338 | |
RegionR3 | -0.218 | 1.421 | 0.69576 | 1.00000 | |
RegionR4 | 0.584 | 1.421 | 0.45438 | 0.78312 | |
RegionR5 | -0.704 | 1.421 | 0.80296 | 1.00000 | |
RegionR6 | -1.615 | 1.421 | 0.99964 | 1.00000 | |
RegionR7 | -1.488 | 1.421 | 0.99968 | 1.00000 | |
RegionR8 | -1.512 | 1.421 | 0.99968 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.216 | 1.421 | 0.99999 | 1.00000 | |
RegenerationR2 | -0.351 | 1.421 | 0.44122 | 0.84065 | |
RegenerationR3 | 2.614 | 1.421 | 0.06381 | 0.42593 | |
RegenerationR4 | 0.824 | 1.421 | 0.55552 | 0.89457 | |
RegenerationR5 | -0.651 | 1.421 | 0.39431 | 0.79485 | |
RegenerationR6 | 3.464 | 1.421 | 0.06155 | 0.31152 | |
RegenerationBL | 0.341 | 1.421 | 0.99998 | 1.00000 | |
RegenerationTP | 3.262 | 1.421 | 0.25395 | 0.70181 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
2. | MligTC455_13376 | 101 | 2.1 | Mlig455_040613 | Neo: - Age: - Region-specific R2: 4.973 Region-enriched R2: 6.158/0.00016 |
5.706 | 0.998 | 0.972 | 0.923 | 0.912 | 0.943 | 0.958 | Mlig455_040613 {REF} {Length: 2807} {RNA1310_27894} {RNA815_60961} | |
3. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 4.758 | 0.945 | 0.979 | 0.900 | 0.967 | - | 0.967 | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
4. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 4.745 | 0.997 | 0.925 | 0.922 | 0.950 | - | 0.951 | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
5. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 4.663 | 0.945 | 0.976 | 0.865 | 0.955 | - | 0.922 | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
6. | MligTC455_24953 | 749 | 15.61 | Mlig455_060716 | Neo: - Age: - Region-specific R2: 5.313 Region-enriched R2: 5.509/0.00000 |
CCDC169 | 4.658 | 0.972 | 0.997 | 0.877 | 0.888 | - | 0.924 | Mlig455_060716 {REF} {Length: 1302} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
7. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
4.596 | 0.899 | 0.988 | 0.874 | 0.928 | - | 0.907 | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
8. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
4.549 | 0.892 | 0.944 | 0.751 | 0.973 | - | 0.989 | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
9. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 4.523 | 0.945 | 0.918 | 0.942 | 0.734 | - | 0.984 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
10. | MligTC455_27310 | 77 | 1.61 | Mlig455_002362 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.676 Region-enriched R2: 3.917/0.01447 |
4.517 | 0.857 | 0.935 | 0.910 | 0.836 | - | 0.979 | Mlig455_002362 {REF} {Length: 2243} {RNA1310_27036} {RNA815_28595} | |
11. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
4.51 | 0.943 | 0.898 | 0.761 | - | 0.943 | 0.965 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
12. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
4.483 | 0.770 | 0.964 | 0.821 | 0.963 | - | 0.965 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
13. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 4.438 | 0.702 | 0.959 | 0.908 | 0.943 | - | 0.926 | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
14. | MligTC455_12117 | 38 | 0.78 | Mlig455_013500 | Neo: - Age: - |
4.422 | 0.917 | 0.978 | 0.943 | 0.837 | 0.747 | - | Mlig455_013500 {REF} {Length: 2103} {RNA1310_23237} {RNA815_45659} | |
15. | MligTC455_47261 | 1918 | 39.96 | Mlig455_033946 | Neo: - Age: - Region-specific R2: 4.808 Region-enriched R2: 4.545/0.00000 |
4.364 | - | 0.926 | 0.837 | 0.766 | 0.881 | 0.954 | Mlig455_033946 {REF} {Length: 2098} {RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1310_36725.1, RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1509_18239, RNA1509_26992, RNA1509_32368, RNA815_10268.1} | |
16. | MligTC455_17138 | 283 | 5.89 | Mlig455_029728 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.646 Region-specific R2: 4.824 Region-enriched R2: 5.583/0.00000 |
LRRCC1 | 4.324 | 0.781 | 0.953 | 0.922 | 0.724 | - | 0.944 | Mlig455_029728 {REF} {Length: 1372} {Pfam: Heat shock factor binding protein 1 [PF06825.14, score=68.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=67.8]; Leucine rich repeat [PF13855.8, score=44.9]; Leucine-rich repeat [PF14580.8, score=35.0]; Leucine Rich repeat [PF13516.8, score=21.5]} {Human: ENSG00000133739, LRRCC1, leucine rich repeat and coiled-coil centrosomal protein 1, [RH, Score=402, Expect=3e-122]} {Mouse: ENSMUSG00000027550, Lrrcc1, leucine rich repeat and coiled-coil domain containing 1, [RH, Score=387, Expect=3e-117]} {Dmel: FBgn0032429, CG5446, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00189952, K10D2.8, [Score=65.1, Expect=8e-11]} {Smed: dd_Smed_v6_10086_0_1, dd_Smed_v6_10086_0_1, [RH, Score=443, Expect=2e-139]} {RNA1509_31405, RNA1509_32465} {RNA1310_70756, RNA1509_31405, RNA1509_32465} {RNA1509_31405, RNA1509_32465, RNA815_37567} |
17. | MligTC455_21668 | 84 | 1.74 | Mlig455_024837 | Neo: - |
PPP3R1 | 4.319 | 0.909 | 0.980 | 0.822 | 0.871 | - | 0.737 | Mlig455_024837 {REF} {Length: 1650} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613} {RNA1310_16848.1} {RNA815_6272} |
18. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 4.269 | 0.772 | 0.947 | 0.793 | 0.771 | - | 0.986 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
19. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 4.204 | 0.772 | 0.947 | 0.718 | 0.780 | - | 0.987 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
20. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 4.185 | 0.760 | 0.758 | 0.954 | 0.954 | - | 0.759 | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
21. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 4.101 | 0.893 | - | 0.714 | 0.708 | 0.808 | 0.978 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
22. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 3.897 | 0.986 | 0.998 | - | 0.948 | - | 0.965 | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
23. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
3.823 | 0.997 | 0.990 | 0.881 | 0.955 | - | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
24. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 3.807 | 0.881 | 0.987 | - | 0.954 | - | 0.985 | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
25. | MligTC455_15467 | 225 | 4.69 | Mlig455_000546 | Neo: - Age: Down-Up-Up Region-specific R2: 6.857 Region-enriched R2: 5.997/0.00105 |
3.754 | 0.963 | 0.922 | 0.968 | - | - | 0.901 | Mlig455_000546 {REF} {Length: 844} {Pfam: Pancreatic hormone peptide [PF00159.20, score=42.9]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=39.7, Expect=1e-05]} {RNA1310_53697} {RNA815_26198} | |
26. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
3.742 | 0.994 | 0.994 | 0.821 | 0.933 | - | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
27. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 3.74 | 0.983 | 0.999 | 0.843 | 0.915 | - | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
28. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
3.731 | 0.954 | 0.945 | 0.940 | 0.892 | - | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
29. | MligTC455_15546 | 141 | 2.93 | Mlig455_021744 | Neo: - Age: - |
3.725 | 0.989 | 0.900 | - | 0.962 | - | 0.874 | Mlig455_021744 {REF} {Length: 1839} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.5]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=51.2, Expect=1e-06]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=72.0, Expect=3e-13]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_25364_0_1, dd_Smed_v6_25364_0_1, [RH, Score=197, Expect=7e-59]} {RNA1310_26850} {RNA815_17444} | |
30. | MligTC455_37988 | 67 | 1.41 | Mlig455_008561 | Neo: - Age: - Region-enriched R2: 8.988/0.00000 |
3.724 | 0.990 | 0.990 | 0.828 | 0.916 | - | - | Mlig455_008561 {REF} {Length: 3146} {Pfam: EF-hand domain pair [PF13499.8, score=36.5]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.4]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=104, Expect=1e-26]} {RNA1310_31713.1} {RNA815_36423} | |
31. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
3.696 | 0.884 | 0.980 | 0.863 | 0.969 | - | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
32. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 3.685 | 0.938 | 0.999 | 0.831 | 0.917 | - | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
33. | MligTC455_16199 | 114 | 2.37 | Mlig455_041013, Mlig455_041178 | Neo: Irradiation Age: - Region-enriched R2: 9.007/0.00037 |
3.678 | 0.952 | 0.967 | 0.813 | 0.946 | - | - | Mlig455_041013 {REF} {Length: 3381} {RNA1509_42904} {RNA1310_20434} {RNA815_22064} Mlig455_041178 {REF} {Length: 2722} {RNA1509_42904} {RNA1310_20004} {RNA815_22064} |
|
34. | MligTC455_32575 | 62 | 1.29 | Mlig455_024198 | Neo: - Age: logFC(26M/2M)=-0.353 |
FAT4 | 3.672 | 0.950 | 0.998 | 0.802 | 0.922 | - | - | Mlig455_024198 {REF} {Length: 7971} {Pfam: Cadherin domain [PF00028.19, score=704.5]; Cadherin-like [PF16184.7, score=77.6]; Cadherin-like [PF08266.14, score=39.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=501, Expect=3e-142]; ENSG00000107736, CDH23, cadherin related 23, [Score=498, Expect=1e-141]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=514, Expect=1e-146]; ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=504, Expect=1e-143]} {Dmel: FBgn0284247, ds, dachsous, [Score=457, Expect=3e-129]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=277, Expect=2e-74]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=276, Expect=8e-74]} {RNA1509_24504} {RNA1310_3168, RNA1509_24504} {RNA1509_24504, RNA815_13217} |
35. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 3.655 | 0.990 | 0.973 | 0.788 | 0.904 | - | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
36. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
3.649 | 0.968 | 0.977 | 0.795 | 0.909 | - | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
37. | MligTC455_42841 | 550 | 11.45 | Mlig455_019999 | Neo: - Age: logFC(26M/2M)=-0.374 Region-specific R2: 6.903 Region-enriched R2: 6.896/0.00000 |
DDC | 3.642 | 0.868 | 0.994 | 0.814 | 0.966 | - | - | Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1} |
38. | MligTC455_50827 | 107 | 2.22 | Mlig455_037867 | Neo: - |
WSCD2 | 3.616 | 0.909 | 0.987 | 0.755 | 0.965 | - | - | Mlig455_037867 {REF} {Length: 912} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.9, Expect=4e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.9, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=46.2, Expect=8e-06]} {RNA1509_59284} {RNA1310_52794.1} {RNA815_21749.1} |
39. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 3.615 | 0.926 | 0.986 | 0.809 | 0.894 | - | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
40. | MligTC455_45730 | 87 | 1.81 | Mlig455_020296 | Neo: - Age: Down-Up-Up Region-enriched R2: 8.589/0.00002 |
SSUH2 | 3.603 | 0.977 | 0.725 | 0.957 | 0.944 | - | - | Mlig455_020296 {REF} {Length: 1680} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=197, Expect=3e-59]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=155, Expect=9e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=127, Expect=5e-33]} {RNA1310_19609.2} {RNA815_22113.1} |
41. | MligTC455_49557 | 280 | 5.82 | Mlig455_017273 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.728 Region-specific R2: 3.642 Region-enriched R2: 3.187/0.00196 |
3.595 | - | 0.950 | 0.794 | 0.978 | - | 0.873 | Mlig455_017273 {REF} {Length: 1333} {RNA1509_52848} {RNA1310_64923, RNA1509_52848} {RNA1509_52848, RNA815_51063} | |
42. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 3.594 | 0.988 | 0.887 | 0.788 | 0.931 | - | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
43. | MligTC455_43741 | 196 | 4.08 | Mlig455_018088 | Neo: - Age: Down-Up-Down |
PTBP1 | 3.571 | 0.831 | 0.973 | - | - | 0.788 | 0.979 | Mlig455_018088 {REF} {Length: 2775} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=116.9]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=52.7]; Occluded RNA-recognition motif [PF16842.7, score=26.8]} {Human: ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [Score=258, Expect=8e-80]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [Score=258, Expect=1e-80]; ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-76]} {Mouse: ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [Score=258, Expect=7e-81]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [Score=251, Expect=1e-78]; ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-77]} {Dmel: FBgn0011224, heph, hephaestus, [Score=249, Expect=7e-78]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [Score=234, Expect=1e-72]} {Smed: dd_Smed_v6_1868_0_1, dd_Smed_v6_1868_0_1, [Score=214, Expect=4e-64]} {RNA1509_36451} {RNA1310_3345} {RNA815_23519} |
44. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
3.56 | 0.996 | 0.784 | 0.820 | 0.960 | - | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
45. | MligTC455_44195 | 267 | 5.56 | Mlig455_057666 | Neo: - Age: logFC(26M/2M)=0.586 Region-enriched R2: 4.885/0.00002 |
3.556 | 0.882 | 0.991 | 0.706 | - | - | 0.977 | Mlig455_057666 {REF} {Length: 1757} {RNA1509_45654, RNA1509_50922} {RNA1310_26801.2, RNA1509_45654, RNA1509_50922} {RNA1509_45654, RNA1509_50922, RNA815_13136} | |
46. | MligTC455_19758 | 53 | 1.1 | Mlig455_002464 | Neo: - Age: - Region-enriched R2: 6.578/0.02863 |
3.55 | 0.990 | 0.721 | 0.856 | 0.983 | - | - | Mlig455_002464 {REF} {Length: 2549} {RNA1310_38437} {RNA815_40458} | |
47. | MligTC455_43561 | 47 | 0.98 | Mlig455_019076, Mlig455_064291 | Neo: - Age: - |
ASIC3 | 3.547 | 0.990 | 0.931 | 0.737 | 0.889 | - | - | Mlig455_019076 {REF} {Length: 2496} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=274.8]} {Human: ENSG00000213199, ASIC3, acid sensing ion channel subunit 3, [RH, Score=122, Expect=5e-29]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=114, Expect=1e-26]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=58.5, Expect=9e-09]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=133, Expect=5e-33]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=127, Expect=4e-31]} {RNA1509_37765} {RNA1310_15854} {RNA815_39159} Mlig455_064291 {REF} {Length: 2206} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=52.6]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=46.6, Expect=1e-06]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=47.8, Expect=1e-07]} {RNA1509_37765} {RNA1310_15854} {RNA815_28789} |
48. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
3.546 | 0.958 | 0.737 | 0.880 | - | - | 0.971 | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
49. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
3.542 | 0.798 | 0.995 | 0.808 | 0.941 | - | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
50. | MligTC455_40051 | 36 | 0.76 | Mlig455_025990 | Neo: - Age: logFC(26M/2M)=-0.633 |
PRKCE | 3.532 | 0.972 | 0.989 | 0.820 | 0.751 | - | - | Mlig455_025990 {REF} {Length: 2622} {Pfam: Protein kinase domain [PF00069.27, score=102.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.5]; Kinase-like [PF14531.8, score=19.5]} {Human: ENSG00000171132, PRKCE, protein kinase C epsilon, [Score=84.3, Expect=1e-16]} {Mouse: ENSMUSG00000045038, Prkce, protein kinase C, epsilon, [Score=82.0, Expect=5e-16]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=79.0, Expect=2e-15]} {Celegans: WBGene00009793, pkn-1, Protein Kinase N (PKN) homolog, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_8010_0_1, dd_Smed_v6_8010_0_1, [Score=77.8, Expect=4e-15]} {RNA1509_36146} {RNA1310_24732} {RNA815_64704} |
51. | MligTC455_50464 | 64 | 1.34 | Mlig455_007906, Mlig455_008010 | Neo: - Age: - |
3.522 | - | 0.796 | - | 0.858 | 0.894 | 0.974 | Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} |
|
52. | MligTC455_33538 | 789 | 16.45 | Mlig455_051129, Mlig455_051205 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.262 Region-specific R2: 4.638 Region-enriched R2: 3.952/0.00052 |
LRRIQ4 | 3.52 | 0.828 | 0.982 | 0.814 | 0.896 | - | - | Mlig455_051129 {REF} {Length: 1662} {Pfam: Leucine rich repeat [PF13855.8, score=77.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=61.4]} {Human: ENSG00000188306, LRRIQ4, leucine rich repeats and IQ motif containing 4, [Score=95.5, Expect=6e-21]; ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [Score=93.6, Expect=4e-20]; ENSG00000130224, LRCH2, leucine rich repeats and calponin homology domain containing 2, [Score=93.2, Expect=4e-20]; ENSG00000163827, LRRC2, leucine rich repeat containing 2, [Score=92.4, Expect=2e-20]; ENSG00000033122, LRRC7, leucine rich repeat containing 7, [Score=91.7, Expect=2e-19]} {Mouse: ENSMUSG00000070056, Mfhas1, malignant fibrous histiocytoma amplified sequence 1, [Score=115, Expect=9e-28]} {Dmel: FBgn0033984, Lap1, [Score=86.3, Expect=4e-18]} {Celegans: WBGene00002632, let-413, [Score=90.5, Expect=1e-19]} {Smed: dd_Smed_v6_17742_0_1, dd_Smed_v6_17742_0_1, [RH, Score=360, Expect=1e-124]} {RNA1509_30762} {RNA1310_31301} {RNA815_15435} Mlig455_051205 {REF} {Length: 2514} {Pfam: Leucine rich repeat [PF13855.8, score=72.4]; Leucine Rich repeats (2 copies) [PF12799.9, score=59.1]} {Human: ENSG00000188306, LRRIQ4, leucine rich repeats and IQ motif containing 4, [Score=94.7, Expect=1e-20]; ENSG00000130224, LRCH2, leucine rich repeats and calponin homology domain containing 2, [Score=93.2, Expect=4e-20]; ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [Score=92.8, Expect=6e-20]; ENSG00000163827, LRRC2, leucine rich repeat containing 2, [Score=92.4, Expect=2e-20]; ENSG00000033122, LRRC7, leucine rich repeat containing 7, [Score=91.3, Expect=3e-19]} {Mouse: ENSMUSG00000070056, Mfhas1, malignant fibrous histiocytoma amplified sequence 1, [Score=115, Expect=1e-27]} {Dmel: FBgn0033984, Lap1, [Score=85.5, Expect=9e-18]} {Celegans: WBGene00002632, let-413, [Score=90.5, Expect=1e-19]} {Smed: dd_Smed_v6_17742_0_1, dd_Smed_v6_17742_0_1, [RH, Score=362, Expect=2e-125]} {RNA1509_30762} {RNA1310_31301, RNA1509_30762} {RNA1509_30762, RNA815_15435} |
53. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 3.513 | 0.717 | 0.952 | - | 0.857 | - | 0.987 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
54. | MligTC455_43981 | 82 | 1.71 | Mlig455_043913 | Neo: - Age: logFC(26M/2M)=-0.628 |
3.501 | 0.971 | 0.925 | 0.770 | 0.835 | - | - | Mlig455_043913 {REF} {Length: 3235} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=165.2]} {Dmel: FBgn0039679, ppk19, pickpocket 19, [Score=53.9, Expect=3e-07]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=56.2, Expect=5e-08]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [Score=72.0, Expect=3e-13]} {RNA1310_43117} {RNA815_28951} | |
55. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
3.499 | - | 0.717 | 0.870 | 0.930 | - | 0.982 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
56. | MligTC455_35417 | 539 | 11.23 | Mlig455_025920, Mlig455_025952 | Neo: - Age: - Region-enriched R2: 3.849/0.00283 |
3.498 | 0.758 | 0.979 | 0.823 | 0.938 | - | - | Mlig455_025920 {REF} {Length: 3607} {RNA1509_50554, RNA1509_8462} {RNA1310_23985, RNA1509_50554} {RNA1509_50554, RNA815_9218.1} Mlig455_025952 {REF} {Length: 3531} {RNA1509_48873, RNA1509_8462} {RNA1310_23985, RNA1509_48873} {RNA1509_48873, RNA815_9218.1} |
|
57. | MligTC455_17778 | 198 | 4.12 | Mlig455_021327 | Neo: - Age: - |
3.49 | 0.812 | - | 0.788 | - | 0.938 | 0.952 | Mlig455_021327 {REF} {Length: 416} {TRANSSPLICED} {RNA1509_23323} {RNA1310_114939} | |
58. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
3.489 | 0.738 | 0.986 | 0.787 | 0.978 | - | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
59. | MligTC455_26092 | 67 | 1.39 | Mlig455_048489 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.677 Region-enriched R2: 4.303/0.01110 |
3.487 | - | 0.794 | 0.780 | 0.966 | - | 0.947 | Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719} | |
60. | MligTC455_27786 | 197 | 4.11 | Mlig455_001303 | Neo: - Age: Up-Down-Down Region-specific R2: 6.990 Region-enriched R2: 6.421/0.02381 |
HMCN2 | 3.487 | 0.757 | 0.999 | 0.815 | 0.916 | - | - | Mlig455_001303 {REF} {Length: 2154} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.5]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=5e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_4579} {RNA1310_19586} {RNA815_17693} |
61. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 3.478 | - | 0.885 | 0.805 | 0.807 | - | 0.981 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
62. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
3.475 | 0.801 | - | 0.777 | - | 0.976 | 0.921 | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
63. | MligTC455_43851 | 79 | 1.64 | Mlig455_031738 | Neo: - Age: - |
PI16 | 3.472 | 0.754 | 0.990 | 0.865 | 0.863 | - | - | Mlig455_031738 {REF} {Length: 2697} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=65.5]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=82.4, Expect=4e-16]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=83.2, Expect=2e-16]} {Dmel: FBgn0038126, CG8483, [Score=48.5, Expect=9e-06]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=139, Expect=3e-35]} {RNA1509_36211} {RNA1310_15740, RNA1509_36211} {RNA1509_36211, RNA815_1860.1} |
64. | MligTC455_45597 | 116 | 2.41 | Mlig455_049417 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.185/0.02405 |
3.464 | 0.987 | 0.903 | 0.710 | 0.864 | - | - | Mlig455_049417 {REF} {Length: 1106} {RNA1310_45744} {RNA815_56662} | |
65. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
3.451 | 0.913 | - | 0.747 | - | 0.813 | 0.978 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
66. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
3.443 | 0.704 | 0.982 | 0.827 | 0.930 | - | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
67. | MligTC455_27684 | 8324 | 173.41 | Mlig455_067482, Mlig455_067490 | Neo: - Age: Down-Up-Up Region-specific R2: 3.632 Region-enriched R2: 2.544/0.00000 |
3.412 | 0.743 | 0.895 | - | 0.961 | - | 0.813 | Mlig455_067482 {REF} {Length: 709} {RNA1509_3821} {RNA1310_17576.1} {RNA815_6182.1} Mlig455_067490 {REF} {Length: 963} {RNA1509_20366, RNA1509_3821} {RNA1310_17576.1, RNA1509_20366, RNA1509_3821} {RNA1509_20366, RNA1509_3821, RNA815_6182.1} |
|
68. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
3.412 | 0.876 | - | 0.726 | - | 0.849 | 0.961 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
69. | MligTC455_41537 | 411 | 8.57 | Mlig455_058671 | Neo: - |
CCDC170 | 3.408 | - | 0.809 | 0.780 | - | 0.865 | 0.954 | Mlig455_058671 {REF} {Length: 4116} {Human: ENSG00000120262, CCDC170, coiled-coil domain containing 170, [RH, Score=284, Expect=8e-84]} {Mouse: ENSMUSG00000019767, Ccdc170, coiled-coil domain containing 170, [RH, Score=274, Expect=4e-80]} {Dmel: FBgn0263079, CG43338, [RH, Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_10140_0_1, dd_Smed_v6_10140_0_1, [RH, Score=304, Expect=4e-91]} {RNA1509_3115} {RNA1310_2598, RNA1509_3115} {RNA1509_3115, RNA815_746} |
70. | MligTC455_26174 | 66 | 1.38 | Mlig455_028738 | Neo: Int S/G2/M Age: Down-Down-Down, logFC(26M/2M)=-0.756 Region-enriched R2: 6.540/0.00000 |
NYNRIN | 3.405 | 0.806 | 0.975 | 0.918 | - | 0.706 | - | Mlig455_028738 {REF} {Length: 5086} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=102.2]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=96.7]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.6]; Integrase zinc binding domain [PF17921.3, score=52.2]; Integrase core domain [PF00665.28, score=45.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=30.4]; Aspartyl protease [PF13650.8, score=19.6]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=74.3, Expect=8e-13]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=74.7, Expect=5e-13]; ENSMUSG00000085925, Rtl1, retrotransposon Gaglike 1, [Score=73.2, Expect=2e-12]; ENSMUSG00000098639, Rtl1, retrotransposon Gaglike 1, [Score=73.2, Expect=2e-12]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=260, Expect=5e-73]} {RNA1509_38388} {RNA1310_4763.1} {RNA815_16141} |
71. | MligTC455_35446 | 75 | 1.56 | Mlig455_031433 | Neo: - Age: Down-Up-Up |
3.404 | 0.984 | 0.891 | 0.765 | 0.764 | - | - | Mlig455_031433 {REF} {Length: 1430} {NoTransDecoderORF} {RNA1310_35373} {RNA815_22739} | |
72. | MligTC455_50014 | 27 | 0.56 | Mlig455_003397 | Neo: - Age: - Region-enriched R2: 6.842/0.00677 |
3.394 | 0.974 | 0.737 | 0.798 | - | - | 0.885 | Mlig455_003397 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_99134} | |
73. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 3.368 | 0.998 | 0.771 | 0.829 | 0.770 | - | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
74. | MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
3.359 | 0.777 | - | 0.815 | 0.816 | - | 0.951 | Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} | |
75. | MligTC455_11494 | 99 | 2.06 | Mlig455_055605 | Neo: - Age: Down-Up-Down |
HS3ST5 | 3.351 | - | 0.737 | 0.763 | - | 0.871 | 0.980 | Mlig455_055605 {REF} {Length: 2196} {Pfam: Sulfotransferase domain [PF00685.29, score=91.7]; Sulfotransferase family [PF13469.8, score=45.8]} {Human: ENSG00000249853, HS3ST5, heparan sulfate-glucosamine 3-sulfotransferase 5, [RH, Score=256, Expect=1e-82]} {Mouse: ENSMUSG00000044499, Hs3st5, heparan sulfate (glucosamine) 3-O-sulfotransferase 5, [RH, Score=257, Expect=2e-83]} {Dmel: FBgn0031005, Hs3st-B, Heparan sulfate 3-O sulfotransferase-B, [Score=205, Expect=9e-63]} {Celegans: WBGene00044303, hst-3.2, Heparan SulphoTransferase, [Score=215, Expect=7e-68]} {Smed: dd_Smed_v6_81402_0_1, dd_Smed_v6_81402_0_1, [Score=123, Expect=7e-34]} {RNA1310_37118} {RNA815_58609} |
76. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 3.272 | - | 0.782 | 0.804 | - | 0.733 | 0.953 | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
77. | MligTC455_18122 | 1083 | 22.57 | Mlig455_020157 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.614 Region-specific R2: 4.994 Region-enriched R2: 4.087/0.00011 |
3.259 | 0.818 | 0.959 | 0.767 | - | - | 0.715 | Mlig455_020157 {REF} {Length: 2290} {RNA1310_56029} {RNA815_34539} | |
78. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 3.235 | - | - | 0.710 | 0.773 | 0.781 | 0.971 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
79. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
2.913 | 0.976 | 0.983 | - | 0.954 | - | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
80. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
2.912 | 0.976 | 0.982 | - | 0.954 | - | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
81. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
2.888 | 0.976 | 0.982 | - | 0.930 | - | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
82. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 2.878 | - | 0.959 | - | - | 0.940 | 0.979 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
83. | MligTC455_40011 | 150 | 3.12 | Mlig455_004436, Mlig455_004448 | Neo: - |
2.876 | - | 0.931 | 0.979 | 0.966 | - | - | Mlig455_004436 {REF} {Length: 595} {RNA1310_81676} Mlig455_004448 {REF} {Length: 1192} {RNA1310_81676} |
|
84. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 2.856 | 0.936 | - | - | 0.957 | - | 0.963 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
85. | MligTC455_34693 | 336 | 7 | Mlig455_017459 | Neo: - Age: - Region-enriched R2: 6.024/0.00000 |
FZD4 | 2.85 | 0.947 | 0.976 | - | 0.927 | - | - | Mlig455_017459 {REF} {Length: 3882} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=335.8]; Fz domain [PF01392.24, score=90.0]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=424, Expect=3e-141]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=423, Expect=3e-141]} {Dmel: FBgn0001085, fz, frizzled, [Score=306, Expect=2e-95]} {Celegans: WBGene00003006, lin-17, Transmembrane receptor LIN-17, [RH, Score=271, Expect=1e-82]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=473, Expect=3e-160]} {RNA1509_10294} {RNA1310_2672} {RNA815_3209} |
86. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
2.846 | 0.914 | 0.981 | - | 0.951 | - | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
87. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
2.843 | 0.938 | - | - | - | 0.936 | 0.969 | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
88. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
2.841 | 0.916 | - | - | - | 0.960 | 0.965 | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
89. | MligTC455_37989 | 83 | 1.72 | Mlig455_018192 | Neo: - Age: - |
2.833 | - | 0.970 | 0.894 | 0.969 | - | - | Mlig455_018192 {REF} {Length: 1275} {Pfam: EF-hand domain pair [PF13499.8, score=36.8]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.5]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=105, Expect=6e-27]} {RNA1310_31713.1} {RNA815_36423} | |
90. | MligTC455_16311 | 89 | 1.86 | Mlig455_053827, Mlig455_068518 | Neo: - Age: - Region-enriched R2: 5.249/0.01530 |
CALML3 | 2.818 | 0.923 | 0.995 | - | 0.900 | - | - | Mlig455_053827 {REF} {Length: 1659} {Pfam: EF-hand domain pair [PF13499.8, score=64.3]; EF hand [PF00036.34, score=58.1]; EF-hand domain [PF13405.8, score=55.1]; EF hand [PF13202.8, score=37.9]; EF-hand domain pair [PF13833.8, score=32.8]; EF-hand domain [PF14658.8, score=20.4]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=96.7, Expect=3e-25]; ENSG00000143933, CALM2, calmodulin 2, [Score=96.7, Expect=6e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.3, Expect=3e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.3, Expect=3e-25]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.3, Expect=2e-25]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.3, Expect=2e-25]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.3, Expect=2e-25]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=95.9, Expect=2e-25]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.1, Expect=7e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.4, Expect=5e-26]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=97.4, Expect=4e-26]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_35579} Mlig455_068518 {REF} {Length: 1007} {Pfam: EF-hand domain pair [PF13499.8, score=64.3]; EF hand [PF00036.34, score=58.1]; EF-hand domain [PF13405.8, score=55.1]; EF hand [PF13202.8, score=38.0]; EF-hand domain pair [PF13833.8, score=33.0]; EF-hand domain [PF14658.8, score=20.4]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=96.7, Expect=2e-25]; ENSG00000143933, CALM2, calmodulin 2, [Score=96.7, Expect=6e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.3, Expect=3e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.3, Expect=3e-25]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.3, Expect=2e-25]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.3, Expect=2e-25]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.3, Expect=2e-25]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=95.9, Expect=3e-25]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.1, Expect=7e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.1, Expect=5e-26]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=97.1, Expect=4e-26]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_35579} |
91. | MligTC455_50039 | 12 | 0.24 | Mlig455_051694 | Neo: - Age: logFC(26M/2M)=2.792 |
2.812 | - | - | 0.907 | - | 0.940 | 0.965 | Mlig455_051694 {REF} {Length: 2204} {TRANSSPLICED} {RNA1310_42392} {RNA815_12871} | |
92. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
2.802 | - | 0.943 | 0.876 | 0.983 | - | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
93. | MligTC455_34692 | 37 | 0.77 | Mlig455_017379 | Neo: - Age: - |
2.796 | 0.928 | - | 0.914 | 0.954 | - | - | Mlig455_017379 {REF} {Length: 579} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_10294} {RNA1310_2672} {RNA815_25099} | |
94. | MligTC455_35894 | 23 | 0.48 | Mlig455_029906 | Neo: - Age: - |
RYK | 2.796 | - | - | - | 0.853 | 0.982 | 0.961 | Mlig455_029906 {REF} {Length: 3571} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=210.1]; WIF domain [PF02019.20, score=110.2]; Protein kinase domain [PF00069.27, score=79.8]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=7e-57]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=202, Expect=9e-57]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=241, Expect=7e-71]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [RH, Score=179, Expect=9e-49]} {Smed: dd_Smed_v6_12594_0_3, dd_Smed_v6_12594_0_3, [Score=201, Expect=2e-56]} {RNA1509_58811} {RNA1310_6671.2, RNA1509_58811} {RNA1509_58811, RNA815_41921} |
95. | MligTC455_41762 | 102 | 2.13 | Mlig455_032244 | Neo: - |
KREMEN2 | 2.79 | - | 0.990 | 0.857 | 0.943 | - | - | Mlig455_032244 {REF} {Length: 1054} {Pfam: WSC domain [PF01822.21, score=60.0]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.0, Expect=3e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]; ENSMUSG00000020811, Wscd1, WSC domain containing 1, [Score=50.4, Expect=8e-07]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.9, Expect=3e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=57.4, Expect=4e-09]} {RNA1509_59284} {RNA1310_42674} {RNA815_21749.1} |
96. | MligTC455_50660 | 81 | 1.7 | Mlig455_019591 | Neo: - Age: - |
SLC9B2 | 2.788 | - | 0.942 | - | - | 0.876 | 0.970 | Mlig455_019591 {REF} {Length: 2686} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=30.0]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=124, Expect=1e-31]} {Mouse: ENSMUSG00000037994, Slc9b2, solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2, [Score=116, Expect=1e-28]; ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [Score=112, Expect=2e-27]} {Dmel: FBgn0263390, Nha2, Na[+]/H[+] hydrogen antiporter 2, [Score=113, Expect=1e-27]} {Celegans: WBGene00009618, F41E7.2, [Score=70.9, Expect=2e-13]} {Smed: dd_Smed_v6_7736_0_1, dd_Smed_v6_7736_0_1, [Score=148, Expect=1e-43]} {RNA1509_34461} {RNA1310_39553.1} {RNA815_32589} |
97. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
2.779 | 0.874 | 0.945 | - | 0.960 | - | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
98. | MligTC455_12037 | 183 | 3.81 | Mlig455_016647, Mlig455_016711 | Neo: - Age: Down-Up-Up |
DYNLL1 | 2.772 | - | 0.987 | 0.804 | 0.981 | - | - | Mlig455_016647 {REF} {Length: 879} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=7e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.5, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=6e-13]} {Smed: dd_Smed_v6_10084_0_2, dd_Smed_v6_10084_0_2, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} Mlig455_016711 {REF} {Length: 890} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=5e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.8, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=5e-13]} {Smed: dd_Smed_v6_10084_0_5, dd_Smed_v6_10084_0_5, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} |
99. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
2.768 | 0.983 | - | - | 0.954 | - | 0.831 | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
100. | MligTC455_42968 | 1407 | 29.31 | Mlig455_016645 | Neo: - |
CCDC105 | 2.766 | - | 0.861 | - | - | 0.976 | 0.929 | Mlig455_016645 {REF} {Length: 2773} {Pfam: Tektin family [PF03148.16, score=79.1]} {Human: ENSG00000160994, CCDC105, coiled-coil domain containing 105, [RH, Score=121, Expect=1e-29]} {Mouse: ENSMUSG00000078442, Ccdc105, coiled-coil domain containing 105, [RH, Score=131, Expect=3e-33]} {Smed: dd_Smed_v6_14773_0_1, dd_Smed_v6_14773_0_1, [RH, Score=226, Expect=3e-70]} {RNA1509_10605, RNA1509_18742, RNA1509_43341} {RNA1310_6775.1, RNA1509_10605, RNA1509_18742, RNA1509_43341} {RNA1509_10605, RNA1509_18742, RNA1509_43341, RNA815_2314.1} |